SLIDING SCALE GLUCOSE GROUP PRESENTATION

riyadhabraham187 369 views 14 slides Oct 08, 2024
Slide 1
Slide 1 of 14
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14

About This Presentation

Group presentation on sliding scale


Slide Content

NIGTHINGALE SCHOOL OF NURSING ANATOMY III GROUP PRESENTATION On SLIDING SCALE TUTOR: Mr. STEPHEN OBENG ASANTE DATE: 12 th NOVEMBER,2019

GROUP 6 MEMBERS IBRAHIM RIYADH ESHUN GLADYS ACQUAH. Q. VICTORIA QUANSAH. O. DEBORAH CYNTHIA TETTEH KUMI PARMELA DADOTO MARTHA MAVIS LONDON NORA BAIDOO. A. THERESAH ASIMEH LINDA DASSAH JENIFFER          

SLIDING SCALE

At the end of this presentation, students must be able to know some knowledge about : What WE MEANT BY SLIDING SCLAE TYPES OF INSULIN HOW SLIDING SCALE INSULIN THERAPY WORKS BLOOD SUGAR RANGES SLIDING SCALE CHART PROBLEMS WHEN USING SLIDING SCALE CLINICAL CORRELATION CONCLUSION REFERENCES QUESTIONS AND ANSWERS

Introduction: Sliding scale insulin therapy is a method used to control blood sugar levels in diabetic patients. With this method, the dose is based on the patient's blood sugar level just before meal. The higher the blood sugar, the more insulin needed.

TYPES OF INSULIN: RAPID-ACTING SHORT-ACTING INTERMEDIATE - ACTING LONG-ACTING PRE-MIXED INSULIN

HOW SLIDING SCALE INSULIN THERAPY WORKS In most sliding-scale insulin therapy regimens, your blood sugar is taken using a glucometer. This is done about four times a day (every five to six hours, or before meal and at bedtime). The amour of insulin you get at meal time is based on your blood sugar measurement.

BLOOD SUGAR RANGES: FASTING BLOOD SUGAR: 3.8 -5.5 mmol/L RANDOM BLOOD SUGAR: 5.5 -7.8 mmol/L PREDIABETES: 5.5 – 6.9 mmol/L ( FBS) DIABETES: >7 MMOL/L (FBS)

SLIDING SCALE CHART BLOOD GLUCOSE (mg/dl) BLOOD GLUCOSE (mmol/L) INSULIN (units) 61- 150   3.4 – 8.3 151 – 200   8.4 – 11.1 3 201 – 250 11.2 – 13.9   5 251 – 300 13.9 – 16.7 8   301 -350 16.7 – 19.4   10 351 – 400 19.5 – 22.2   12 >400   >22.2 15

PROBLEMS WHEN USING SLIDING SCALE POOR BLOOD SUGAR CONTROL: NO PERSONALIZATION DIET WEIGHT FACTORING

CLINICAL CORRELATION HYPERGLYCEMIA HYPOGLYCEMIA DIABETES MELLITUS

CONCLUSION Sliding-scale insulin therapy (SSI) is mostly used in hospitals due to its simple way to control blood sugar. This helps keep patient blood sugar in a normal range, prevent high blood sugar levels and also prevent complications.

REFRENCES: American Diabetes Association (2014). "Diagnosis and Classification of Diabetes Mellitus". Diabetes Care. 37: S81–S90. Doi: 10.2337/dc14-s081. PMC 3632174. PMID 24357215. Pais I, Hallschmid M, Jauch-Chara K, et al. (2007). "Mood and cognitive functions during acute euglycaemia and mild hyperglycaemia in type 2 diabetic patients". Exp. Clin. Endocrinol. Diabetes. 115 (1): 42–46. Doi: 10.1055/s-2007-957348. PMID 17286234. Sommerfield AJ, Deary IJ, Frier BM (2004). "Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes". Diabetes Care. 27 (10): 2335–40. doi:10.2337/diacare.27.10.2335. PMID 15451897. Geijselaers, Stefan L.C.; Sep, Simone J.S.; Claessens, Danny; Schram, Miranda T.; Van Boxtel, Martin P.J.; Henry, Ronald M.A.; Verhey, Frans R.J.; Kroon, Abraham A.; Dagnelie, Pieter C.; Schalkwijk, Casper G.; Van Der Kallen, Carla J.H.; Biessels, Geert Jan; Stehouwer, Coen D.A. (2017). "The Role of Hyperglycemia, Insulin Resistance, and Blood Pressure in Diabetes-Associated Differences in Cognitive Performance—The Maastricht Study". Diabetes Care. 40 (11): 1537–1547. Doi: 10.2337/dc17-0330. PMID 28842522. Kraemer, Fredric B.; Shen, Wen-Jun (2002). "Hormone-sensitive lipase". Journal of Lipid Research. 43 (10): 1585–1594. doi:10.1194/jlr.R200009-JLR200. ISSN 0022-2275. PMID 12364542. "Chronic hyperglycemia may lead to cardiac damage". Journal of the American College of Cardiology. 2012-02-03. Retrieved 3 February 2012. Miller, Miller’s Anesthesia, 7th edition, pp. 1716, 2674, 2809. Cetin M, Yetgin S, Kara A, et al. (1994). "Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia". J Med. 25 (3–4): 219–29. PMI 7996065.

QUESTIONS AND ANSWERS